MedTrace Logo

LEAF - Low Energy In Atrial Fibrillation

NCT00157781 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 237

Last updated 2025-07-03

No results posted yet for this study

Summary

The purpose of the study is to demonstrate the efficiency on AT / AF prevention and termination of a new algorithm contained in the Medtronic AT500 Antitachycardia device in patients with conventional pacemaker indications.

Conditions

Interventions

DEVICE

Medtronic AT500

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Kacet Salem, Prof. · University Hospital, Lille

  • Mabo Philippe, Prof. · CHU Rennes,France

  • Pisipia André, Dr. · Hopital St Joseph - Marseille - France

  • Frank Robert, Dr. · CHU Pitié-Salpétrière - Paris - France

  • Attuel Patrick, Dr. · Clinique Parly 2 - le Chesnay - France

  • Aliot Etienne, Prof. · CHU Nancy - France

  • le Heuzey Jean Yves, Prof. · HEGP Paris - France

  • Davy Jean Marc, prof. · CHU Montpellier - France

  • Defaye Pascal, Dr · CHU Grenoble - France

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-08-31
Completion
2003-11-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00157781 on ClinicalTrials.gov